Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. - Brown, Michelle L; Motsch, Johann; Kaye, Keith S; File, Thomas M; Boucher, Helen W; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert W; Du, Jiejun; DePestel, Daryl D; Butterton, Joan R; et al. (Open Forum Infectious Diseases, 2020)